Evidence map›Paper›PMID 23838110›Full record

ArticleCirculation. Cardiovascular quality and outcomes2013

Evidence of systematic duplication by new percutaneous coronary intervention programs.

Thomas W Concannon, Jason Nelson, David M Kent, John L Griffith

Erratum issuedAbstract read
In one paragraph

Article in Circulation. Cardiovascular quality and outcomes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Is more better? A multilevel analysis of percutaneous coronary intervention hospital openings and closures on patient volumes.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Differential benefits of cardiac care regionalization based on driving time to percutaneous coronary intervention.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Thomas W ConcannonThe RAND Corporation, Boston, MA 02116, USA. tconcann@rand.org
Jason Nelson
David M Kent
John L Griffith

Funding

TUFTS CLINICAL AND TRANSLATION SCIENCE INSTITUTE (UL1): BPCAUL1RR025752 · NCRR · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2008 to 2011
$17.6M
Tufts Clinical and Translation Science Institute (UL1)UL1TR000073 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2012 to 2013
$5.5M
Triage and Allocation Model for Primary PCI After STEMIK01HS017726 · AHRQ · TUFTS MEDICAL CENTER · PI CONCANNON, THOMAS W. · 2008 to 2012
$541k
AHRQ HHS K01 HS017726NCATS NIH HHS UL1 TR000073NCRR NIH HHS UL1 RR025752
6 · The paper itself

Abstract

backgroundEvidence suggests that recent and projected future investments in percutaneous coronary intervention (PCI) programs at US hospitals fail to increase access to timely reperfusion for patients with ST-segment elevation myocardial infarction. METHODS AND

resultsWe set out to estimate the annual number and costs of new PCI programs in US hospitals from 2004 to 2008 and identify the characteristics of hospitals, neighborhoods, and states where new PCI programs have been introduced. We estimated a discrete-time hazard model to measure the influence of these characteristics on the decision of a hospital to introduce a new PCI program. In 2008, 1739 US hospitals were capable of performing PCI, a relative increase of 16.5% (251 hospitals) over 2004. The percentage of the US population with projected access to timely PCI grew by 1.8%. New PCI programs were more likely to be introduced in areas that already had a PCI program with more competition for market share, near populations with higher rates of private insurance, in states that had weak or no regulation of new cardiac catheterization laboratories, and in wealthier and larger hospitals.

conclusionsOur data show that new PCI programs were systematically duplicative of existing programs and did not help patients gain access to timely PCI. The total cost of recent US investments in new PCI programs is large and of questionable value for patients.

Indexed as

Delivery of Health CareHealth Services AccessibilityHospitalsPercutaneous Coronary InterventionTime-to-TreatmentCensusesCost-Benefit AnalysisForecastingHealth Care SurveysHealth Services Needs and DemandHealth Services ResearchHospital CostsHumansMyocardial InfarctionNeeds AssessmentProportional Hazards Modelsangioplastycatheterizationmappingpercutaneous coronary interventionST-segment elevation myocardial infarction

Identifiers

PMID23838110
PMCPMC4436967

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.